Friday, July 10, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Autoimmune & immunology · Phase I

Autoimmune & immunology programs at Phase I — ClinicalTrials.gov pipeline intelligence.

Programs 167

Quick answer

Autoimmune & immunology Phase I programs: NovaPharmaNews indexes 167 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.

Top sponsors

Pipeline programs

Page 3 of 4

  1. Linperlisib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Autoimmune Hemolytic Anemia

    phase 1 small molecule terminated

    1 trial

  2. M25-433

    AbbVie Deutschland GmbH & Co. KG

    Systemic Lupus Erythematosus, Sjogren's disease

    phase 1 other active

    1 trial

  3. MC-1-50

    Chongqing Precision Biotech Co., Ltd

    Systemic Lupus Erythematosus (SLE)

    phase 1 mab active

    1 trial

  4. MDGN-002

    Avalo Therapeutics

    Crohn Disease

    phase 1 small molecule terminated

    1 trial

  5. MESAL-02-25

    Lacuna Pharma Pty Ltd

    ulcerative colitis

    phase 1 other active

    1 trial

  6. MESAL-03-25

    Lacuna Pharma Pty Ltd

    ulcerative colitis

    phase 1 other active

    1 trial

  7. MESAL-19-24

    Lacuna Pharma Pty Ltd

    ulcerative colitis

    phase 1 other active

    1 trial

  8. MESAL-20-24

    Lacuna Pharma Pty Ltd

    ulcerative colitis

    phase 1 other active

    1 trial

  9. MK-1045-004

    Merck Sharp and Dohme

    Systemic lupus erythematosus, Rheumatoid arthritis

    phase 1 other active

    1 trial

  10. MK-2420 SAD Study

    Merck Sharp and Dohme

    Rheumatoid arthritis

    phase 1 other active

    1 trial

  11. Methotrexate

    Sana Biotechnology

    Chronic Plaque Psoriasis

    phase 1 small molecule active

    1 trial

  12. Methotrexate - Amneal

    Amneal Pharma Europe Ltd

    Psoriasis

    phase 1 small molecule active

    1 trial

  13. Methotrexate PK (in combination with Novobiocin) in RA patients

    Lacuna Pharma Pty Ltd

    Rheumatoid arthritis

    phase 1 other active

    1 trial

  14. Modified Gegen Qinlian Decoction

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Ulcerative Colitis

    phase 1 small molecule active

    1 trial

  15. No Intervention

    Takeda

    Rheumatoid Arthritis

    phase 1 other completed

    1 trial

  16. O3R-5671-CL-101

    Lacuna Pharma Pty Ltd

    Inflammatory bowel diseases and psoriasis.

    phase 1 other active

    1 trial

  17. Obecabtagene autoleucel (obe-cel)

    Autolus GmbH

    Systemic Lupus Erythematosus

    phase 1 mab active

    1 trial

  18. PH-F8IL10INTRA-03/24

    Philogen S.p.A.

    Patients with Rheumatoid Arthritis (RA) who, despite treatment with stable doses (for at least 3 months) of disease-modifying antirheumatic drugs (DMARDs, conventional, biologic and/or targeted synthetic), present arthritis flare(s) suitable for intra-articular (IA) injection in a knee, shoulder, ankle, wrist or elbow.

    phase 1 other active

    1 trial

  19. PIPE-791

    Contineum Therapeutics

    Chronic Osteoarthritis Pain

    phase 1 small molecule completed

    1 trial

  20. PTOC1

    Chongqing Precision Biotech Co., Ltd

    Systemic Lupus Erythematosus

    phase 1 mab active

    1 trial

  21. Phase 1 study on SAR443122 bioavailability and food effect in healthy adults

    Sanofi-aventis Healthcare Pty Ltd

    Colitis ulcerative

    phase 1 other active

    1 trial

  22. Placebo

    Nektar Therapeutics UK Limited

    Psoriasis

    phase 1 small molecule completed

    1 trial

  23. QT-019C

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    SLE - Systemic Lupus Erythematosus

    phase 1 mab active

    1 trial

  24. R5459-1979-LN-2459

    Lacuna Pharma Pty Ltd

    Lupus Nephritis

    phase 1 other active

    1 trial

  25. RA-TL011-101

    Teva Pharma GmbH

    Rheumatoid Arthritis

    phase 1 mab completed

    1 trial

  26. REGN88

    Regeneron UK Limited

    Rheumatoid Arthritis

    phase 1 mab completed

    3 trials

  27. RO7507062

    Hoffmann-La Roche

    Systemic Lupus Erythematosus

    phase 1 small molecule active

    1 trial

  28. Rilonacept

    Regeneron UK Limited

    Autoimmune Neurosensory Hearing Loss (ANSHL)

    phase 1 small molecule active

    1 trial

  29. SAD18258

    Sanofi-aventis Healthcare Pty Ltd

    Osteoarthritis

    phase 1 other active

    1 trial

  30. SC291

    Sana Biotechnology

    Lupus Erythematosus

    phase 1 mab active

    1 trial

  31. SER-287

    Seres Therapeutics

    Ulcerative Colitis

    phase 1 small molecule completed

    1 trial

  32. SOR102-101

    Lacuna Pharma Pty Ltd

    Ulcerative colitis

    phase 1 other active

    1 trial

  33. SPI-62-CL-1002

    Lacuna Pharma Pty Ltd

    polymyalgia rheumatica

    phase 1 other active

    1 trial

  34. SSGJ-613

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Systemic Juvenile Idiopathic Arthritis

    phase 1 small molecule active

    1 trial

  35. SSGJ-613

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Arthritis, Gouty

    phase 1 small molecule active

    1 trial

  36. STRATIFY; Near-infrared fluorescence molecula...

    Disc Medicine

    Crohn's disease, Spondyloarthritis, Rheumatoid arthritis, Ulcerative colitis

    phase 1 other active

    1 trial

  37. Sargramostim

    Ultragenyx UK Limited

    Autoimmune Pulmonary Alveolar Proteinosis

    phase 1 small molecule completed

    1 trial

  38. Signature Cord Prime

    Forteo

    Osteoarthritis, Knee

    phase 1 mab active

    1 trial

  39. Single and multiple ascending dose of ZP9830 in healthy participants

    Zealand Pharma A/S

    Autoimmune diseases

    phase 1 other active

    1 trial

  40. Spesolimab

    Boehringer Ingelheim

    Psoriasis

    phase 1 small molecule completed

    1 trial

  41. Study of GS-0151 in Participants With Rheumatoid Arthritis

    Gilead Sciences Pty Limited

    Rheumatoid Arthritis

    phase 1 other active

    1 trial

  42. TAK-007

    Takeda

    Refractory Lupus Nephritis

    phase 1 mab terminated

    1 trial

  43. TAK-079

    Takeda

    Autoimmune Disease

    phase 1 small molecule completed

    1 trial

  44. TAK-079

    Takeda

    Systemic Lupus Erythematosus

    phase 1 small molecule completed

    1 trial

  45. TD-1473

    Theravance Biopharma Ireland Umited

    Ulcerative Colitis, Active Moderate

    phase 1 small molecule completed

    1 trial

  46. TD-3504

    Theravance Biopharma Ireland Umited

    Active Mild Ulcerative Colitis, Active Moderate Ulcerative Colitis, Healthy Subjects

    phase 1 small molecule completed

    1 trial

  47. TG1101-RMS-SC101

    TG THERAPEUTICS, INC.

    Relapsing multiple sclerosis, Myasthenia Gravis

    phase 1 small molecule active

    1 trial

  48. ThisCART19A

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Autoimmune Hemolytic Anemia

    phase 1 mab active

    1 trial

Frequently asked questions

How many autoimmune & immunology Phase I programs exist?

167 programs match both the therapeutic area and stage filters in our published index.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.